)
Visual
test
Evogene
Evogene (EVGN) investor relations material
Evogene Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary26 Mar, 2026
Company overview and business model
Designs novel, highly potent small molecules for drug development and ag-chemicals using ChemPass AI, a computational generative AI engine.
Shifted strategic focus in 2025 to exclusively develop small molecule products, discontinuing other tech engines and non-core activities.
Operates through three units: computational (ChemPass AI), pharmaceutical (novel small molecules), and agricultural (Ag Plenus subsidiary for ag-chemicals collaborations).
Financial performance and metrics
As of December 31, 2025, cash and cash equivalents were $12.96 million (actual) and $16.06 million (pro forma).
Total equity was $11.98 million (actual) and $11.41 million (pro forma).
Accumulated deficit stood at $282.56 million (actual) and $284.27 million (pro forma).
Use of proceeds and capital allocation
Will receive up to $6.35 million from warrant exercises, intended for R&D, working capital, subsidiary investments, sales and marketing, and general corporate purposes.
May use a portion of proceeds for acquisitions or investments in complementary technologies, products, or businesses.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Evogene
- AI-driven molecular design platform accelerates pharma and ag-chemical innovation and partnerships.EVGN
Corporate presentation23 Mar 2026 - Strategic refocus and cost cuts narrowed net loss to $7.8M despite lower 2025 revenue.EVGNQ4 20255 Mar 2026
- Revenue up, losses down, and H2 growth expected from Casterra seed orders and new products.EVGNQ2 202423 Jan 2026
- Nine-month revenues reached $6.9M, but Q3 net loss rose to $8.2M on higher expenses.EVGNQ3 202412 Jan 2026
- 2024 revenue up 52%, net loss down, and AI drug discovery prioritized for 2025 growth.EVGNQ4 202417 Dec 2025
- AI-powered life-science firm enables resale of 3.38M shares to fund R&D and growth.EVGNRegistration Filing29 Nov 2025
- Revenue up 41%, net loss narrows, and 18-month runway secured through asset sales and equity raise.EVGNQ2 202523 Nov 2025
- AI-driven focus, cost cuts, and asset sales led to profit and improved financials.EVGNQ3 202520 Nov 2025
- Net loss narrowed to $3.0M as cost cuts and asset sales offset lower revenues.EVGNQ1 202513 Nov 2025
Next Evogene earnings date
Q1 202620 May, 2026
Evogene
Next Evogene earnings date
Q1 202620 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage